First-line Therapy for HR-positive, HER2-negative, mBC
William J. Gradishar, MD and Joyce A. O’Shaughnessy, MD provide the setting for the role of first-line therapy for HR-positive, HER2-negative mBC.
William J. Gradishar, MD and Joyce A. O’Shaughnessy, MD provide the setting for the role of first-line therapy for HR-positive, HER2-negative mBC.